Key Features:
- Botulinum neurotoxin type A blocks cholinergic transmission at the neuromuscular junction by inhibiting the release of acetylcholine
- Bocouture is free from complexing proteins
Treatment Areas:
- Glabellar frown lines
- Periorbital lines
- Horizontal forehead lines
Composition:
- Botulinum toxin type A, free from complexing proteins. The additional ingredients are human albumin and sucrose.
Box Contents:
- Box contains one Bocouture 100iu vial
Contraindications of Bocouture:
- Hypersensitivity to the active substance or any of the excipients
- Generalised disorders of muscle activity (e.g. myasthenia gravis, Lambert- Eaton syndrome)
- Infection or inflammation at the proposed injection site
Who Should Not Use Bocouture?
- The injection of Bocouture is not recommended for patients with a history of aspiration or dysphagia
- Patients suffering from amyotrophic lateral sclerosis
- Patients with other diseases which result in peripheral neuromuscular dysfunction
- In targeted muscles that display pronounced weakness or atrophy
Storage:
Additional Information:
EMC: https://www.medicines.org.uk/emc/product/7418/smpc
Patient Information Leaflet: https://www.medicines.org.uk/emc/files/pil.7418.pdf
